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Summary
INTRODUCTION: Smoking is still the most preventable
cause of disease and premature death in Switzerland, as
elsewhere. We aimed to assess the main determinants
of smoking cessation in the population-based cohort of
SAPALDIA (Swiss Cohort Study on Air Pollution and Lung
and Heart Diseases in Adults).
METHODS: The SAPALDIA study was initiated in 1991
with 9651 participants aged 18 to 60 years from eight
areas (S1). Follow-up assessments were conducted in
2002 (S2; 8047 participants) and 2010/11 (S3; 6088 par-
ticipants). At each survey, detailed information on health
and potential health-related factors was collected and lung
function measured. Using logistic regression, we as-
sessed predictors of smoking cessation between S1 and
S2 and between S2 and S3.
RESULTS: In both periods, highest educational level
(summary odds ratio [OR] 1.49, 95% confidence interval
[CI] 1.08–2.06; ref. lowest level), FEV1/FVC <0.5 (OR
6.19, 95% CI 2.44–15.7, ref. FEV1/FVC ≥0.7), higher age
in men (OR 1.02, 95% CI 1.01–1.03, per year) and over-
weight (OR 1.38, 95% CI 1.16–1.64) were significant pre-
dictors of smoking cessation. Nicotine dependence (OR
0.97, 95% CI 0.96–0.98, per cigarette smoked a day) and
female sex between age 45 and 60 (e.g., OR 0.74, 95%
CI 0.61–0.91, at age 50) were negatively associated with
smoking cessation. Moreover, smokers at S2 reporting a
diagnosis of depression were less likely to quit smoking by
S3 (OR 0.53, 95% CI 0.30–0.93).
CONCLUSIONS: Prospective tobacco control policies in
Switzerland should be addressed to women, younger per-
sons and persons of lower education.
Key words: smoking cessation, factors associated with
smoking cessation, COPD and smoking cessation, smok-
ing cessation in Switzerland, SAPALDIA cohort
Introduction
The fight against the tobacco epidemic is a global health
priority. During the 20th century, tobacco smoking killed
about 100 million people and this number is likely to reach
1 billion in the 21st century [1]. Despite numerous interna-
tional tobacco control efforts, smoking is still a top rank-
ing cause of disease and premature death [2]. Six million
people per year die as a consequence of tobacco use, more
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than 600 000 of them as a result of exposure to second-
hand smoke [3].
In Switzerland, more than 9000 deaths were attributable to
smoking in 2007 according to the Federal Office of Sta-
tistics. A quarter of these deaths involved persons under
the age of 65 years and a higher proportion were men. The
three leading causes of smoking-attributable death were
cancer (41%), cardiovascular disease (41%) and respirato-
ry diseases (18%) [4]. Additionally, environmental tobac-
co smoke exposure in public places in Switzerland was
estimated to cause 32 000 additional hospital days and
3000 YLL (years of life lost) owing to lung cancer and is-
chaemic heart disease per year. This corresponds to health-
care costs of 330 million Swiss francs [5].
Recent data from the Swiss national health survey point
to a decreasing trend in smoking prevalence in both sexes
and most age groups [6]. According to national and inter-
national evidence, the most effective measures for tobac-
co control at the population level are structural prevention
measures, such as cigarette pricing and legislation against
smoking in public and work places or against advertise-
ment [1, 7]. Switzerland was late in responding to inter-
national calls for tobacco control and is one of the few
countries that have not yet ratified the World Health Or-
ganization (WHO) tobacco convention. In 2016, the health
committee of the Swiss parliament voted against the prohi-
bition of tobacco advertisement in public places and movie
theatres. All European Union member states have in the
meantime implemented such laws. Switzerland has, how-
ever, increased tobacco taxes and restricted smoking in
public and work places in more recent years. A nation-
wide smoking ban in public places was enforced in 2010.
However, less is known about personal factors influencing
the likelihood of smoking cessation.
Educational level has been identified as an important pre-
dictor of quitting among smokers in Switzerland and the
European Union [6, 8]. However, health variables have not
been well studied as predictors of cessation among Swiss
smokers [6]. Research on these factors can help to tailor
prevention strategies for further reduction of the burden of
tobacco use. The aims of this study were to assess changes
in smoking prevalence and predictors of smoking cessation
between 1991 and 2010/11 in the population-based cohort
of SAPALDIA (which covers culturally and geographical-
ly diverse regions of Switzerland) with a specific focus on
the role of sociodemographic, lifestyle and health-related
factors.
Materials and methods
This study used data from SAPALDIA, a population-based
multicentre cohort study initiated in 1991 with the ob-
jective of studying effects of air pollution on respiratory
health in adults. The SAPALDIA study was conducted in
eight different areas of Switzerland (Aarau, Basel, Davos,
Geneva, Lugano, Montana, Payerne and Wald). Members
of the SAPALDIA team are listed in appendix 1. Partici-
pants aged 18–60 years at the onset were recruited through
random samples drawn from the respective inhabitant reg-
istries. The baseline survey (S1) included 9651 partici-
pants. Later, two follow-up assessments were conducted,
one in 2002 (S2; 8047 participants) and the second one in
2010/11 (S3; 6088 participants).
At each assessment of the SAPALDIA cohort, detailed in-
formation about general health, life-style and living con-
ditions was collected by means of an extensive computer-
based interview at the study centre. In the second and third
survey, self-administered questionnaires and telephone in-
terviews were additionally used. Pulmonary function of
study participants was measured in all three surveys. The
lung function parameters assessed were FVC (forced vital
capacity), FEV1 (forced expiratory volume in the first sec-
ond) and various forced expiratory flow measures. The
FEV1/FVC ratio was calculated for every subject and a
low ratio (defined as <0.7) was considered an indicator of
obstruction to air flow in accordance with the GOLD re-
port definition of Chronic Obstructive Pulmonary Disease
(COPD) [9]. The SAPALDIA methodology has been de-
scribed in detail [10, 11]. All participants gave written in-
formed consent and ethical approval was granted by the
Swiss Academy of Medical Sciences and the respective
cantonal ethics committees.
Study population
For the purpose of this study, two samples were chosen.
The first sample consisted of all smokers at SAPALDIA1
with smoking status known at SAPALDIA2 and sufficient
covariate information at SAPALDIA1 and the second sam-
ple contained all smokers at SAPALDIA2 with smoking
status known at SAPALDIA3 plus sufficient covariate in-
formation at SAPALDIA2 (see section on statistical analy-
sis).
Outcome variables
The outcome variables were “smoking cessation between
S1 and S2” in the sample of smokers in SAPALDIA1 and
“smoking cessation between S2 and S3” in the sample
of smokers in SAPALDIA2. Subjects who reported being
smokers at the beginning of the respective period and non-
smokers at the end were assigned the value 1 in these vari-
ables and will be referred to as quitters.
Being a smoker was defined by a positive answer to both
of the following questions: “Have you ever smoked for as
long as a year?” “Do you now smoke, as of one month
ago?”
Statistical analysis
The proportions of smokers and nonsmokers were assessed
for each of the three surveys according to age, sex, study
area, educational level, nationality and marital status. Pre-
dictors of smoking cessation were studied by using a multi-
variable logistic regression model with the outcome “hav-
ing quitted between respective surveys”. In order to min-
imise the risk of confounding of main results and to be
open to new findings, the selection of independent vari-
ables was broad and limited only by data availability.
All independent variables were defined on the basis of
their values at the beginning of the respective follow-up
period. The first model included variables assessed both
at S1 and S2, i.e., sex, age, study area, education level
(low = primary school; medium = secondary school, mid-
dle school or apprenticeship; high = college or university’),
civil status (married; divorced; widowed; single), nation-
ality (Swiss; Italian, Spanish or Portuguese; western and
northern Europe; eastern Europe; others), smoking inten-
sity (measured by the daily number of cigarettes smoked),
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overweight (defined by a body mass index >25 kg/m2),
level of environmental tobacco smoke exposure (none; less
than 3 hours a day; at least 3 hours a day), asthma (defined
by the question “Did you ever have asthma and was this
asthma confirmed by a doctor?”), chronic cough (defined
by the question “Do you usually cough during the day or
at night, on most days for as much as 3 months each year,
and for at least two years?”), chronic phlegm (defined by
the question “Do you usually bring up any phlegm from
your chest during the day or at night, on most days for as
much as 3 months each year, and for at least two years?”),
and level of chronic obstructive pulmonary disease (FEV1/
FVC ≥0.7, 0.5 ≤FEV1/FVC <0.7, FEV1/FVC <0.5). This
model was applied to smoking cessation between S1 and
S2 among smokers at S1 (i.e., with predictor variables as-
sessed at S1) and to smoking cessation between S2 and S3
among smokers at S2 (i.e., with the same predictor vari-
ables updated at S2). Estimates of both models were then
combined using fixed effects meta-analysis. In a second
step, the model for smoking cessation between S2 and S3
was extended by the following additional predictor vari-
ables only assessed at S2: alcohol consumption (“less than
once a week”; “less than once a day”; “once or two times
a day”; “three times or more per day”); physical activi-
ty (“sufficiently active” = at least 150 min/week of mod-
erate or vigorous activity vs “insufficiently active” = less
than 150 min/week of moderate or vigorous activity); an
indicator variable for “new dog ownership” (i.e., reported
dog ownership in S2 but not in S1); separate indicator vari-
ables for self-reported doctor’s diagnoses of diabetes, can-
cer and depression; an indicator variable for cardiovascular
disease defined as presence of heart disease, hypertension
or stroke, with heart disease having been defined based
on prescribed medications (beta-blockers, angiotensin con-
verting-enzyme [ACE] inhibitors, calcium channel block-
ers or diuretics). In a third model, we additionally included
the eight indices of the SF36 questionnaire on self-per-
ceived, health-related quality of life, representing the do-
mains vitality, physical functioning, bodily pain, general
health perceptions, physical role functioning, emotional
role functioning, social role functioning and mental health
[12]. As these variables may be on the causal pathway
between chronic diseases and the decision to quit smok-
ing, they were not included from the beginning. As FEV1/
FVC is the lung function measure used to define chron-
ic obstructive pulmonary disease (COPD), also known as
“smoker’s disease”, we explored the functional relation-
ship between FEV1/FVC at S1 and the likelihood of quit-
ting smoking between S1 and S2, using a natural cubic
spline function.
Effect modification by sex was assessed using interaction
terms. Gender-specific analyses were also conducted and
their results are presented in supplementary tables S6 and
S7 (appendix 2). As the interaction between sex and age
had a p-value <0.1, effects of age were estimated sepa-
rately for men and women. To address potential bias due
to loss to follow-up, analyses were also performed using
inverse probability weighting. Probability weights for the
analysis of smoking cessation between two consecutive
surveys were derived from logistic regression models of
participation in the second of the two surveys as a function
of variables from the first of the two surveys which were
informative about further participation. The level of statis-
tical significance was defined at 0.05 for main effects and
at 0.1 for interaction effects. All analyses were conducted
in Stata 13.1 (Stata Corp., College Station, USA).
Results
Characteristics of smokers and non-smokers over the
time of follow-up
The sociodemographic characteristics of smokers and non-
smokers are shown in table 1. Similar patterns were ob-
served in all three surveys. Current smoking was more
prevalent in men, persons aged between 30 and 50 years,
persons with low education or of non-Swiss nationality,
and divorced persons. Moreover, smoking was most preva-
lent in Payerne, Basel, Lugano and Geneva.
Overall, the proportion of current smokers declined among
most age groups and areas between S1 and S3. Moreover,
the prevalence of current smoking decreased for both men
(from 38% in S1 to 20% in S3) and women (from 29%
in S1 to 17% in S3). However, the prevalence of current
smoking was higher in males than in females in all three
surveys. The proportion of current smokers also decreased
between S1 and S3 across all educational levels (most
strongly among persons with medium education, with 33%
in S1 and 19% in S3), nationalities (most strongly among
Swiss persons, with 33% in S1 and 18% in S3) and cat-
egories of civil status (most strongly among married per-
sons with 31% in S1 and 15% in S3). Smoking prevalence
remained highest in the lowest educational group, in di-
vorced participants, and in non-Swiss nationals.
Predictors of smoking cessation between S1 and S3
Table 2 shows the odds ratios of smoking cessation be-
tween S1 and S2 among smokers at S1 for predictor vari-
ables from S1 (first column) and of smoking cessation
between S2 and S3 among smokers at S2 for the same vari-
ables re-assessed at S2 (second column). The meta-ana-
lytic summary estimates of the period-specific results are
shown in the third column of the table. The characteris-
tics of the respective samples are given in supplementary
table S1 (appendix 2). Statistically significant predictors of
quitting after meta-analysis of period-specific results were
“being overweight” (odds ratio [OR] 1.38, 95% confidence
interval [CI] 1.16–1.64), “being in the highest education
category” (OR 1.49, 95% CI 1.08–2.06, ref. lowest cate-
gory), “being widowed” (OR 2.21, 95% CI 1.29–3.76, ref.
married), “being divorced” (OR 1.35, 95% CI 1.04–1.76,
ref. married) and “having a Tiffeneau ratio FEV1/FVC
<0.5” (OR 6.19, 95% CI 2.44–15.7, ref. FEV1/FVC ≥0.7).
Age showed a significant positive association with quitting
(OR 1.02, 95% CI 1.01–1.03, per year of age) in men,
whereas no association with age was found in women.
In contrast, women between age 45 (OR 0.79, 95% CI
0.66–0.95) and age 60 (OR 0.63, 95% CI 0.47–0.84) and
smokers with a higher daily consumption of cigarettes (OR
0.97, 95% CI 0.96–0.98 per cigarette) were significantly
less likely to quit. Smokers with chronic cough (OR 0.94,
95% CI 0.69–1.27), chronic phlegm (OR 0.77, 95% CI
0.51–1.16) or asthma (OR 0.77, 95% CI 0.54–1.08) were
also less likely to quit. No significant differences were
found according to area or nationality. Some associations
got considerably stronger in the second period. Both high
and medium as compared to low education became sig-
Original article Swiss Med Wkly. 2017;147:w14502
Swiss Medical Weekly · PDF of the online version · www.smw.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 3 of 17
nificant predictors of smoking cessation, with odds ratios
above 2.5 in both cases. Moreover, smokers with asthma
were significantly less likely to quit than those who did not
report having asthma. On the other hand, the gender differ-
ence decreased.
Additional predictors of smoking cessation between S2
and S3
The multivariable logistic regression analysis relating
characteristics of smokers newly assessed at S2 to smoking
cessation between S2 and S3 was performed in two con-
secutive regression models, the first one without and the
second one including the SF36 variables. Both models also
included the variables listed in table 2. The results of the
first model are given in table 3.
Smokers reporting depression at S2 were significantly less
likely to quit smoking by S3 (OR 0.53, 95% CI 0.30–0.93)
than those who did not report this disease. Compared with
smokers drinking alcohol less than once a week, the like-
lihood of smoking cessation by S3 was significantly lower
among those drinking alcohol once or twice a day (OR
0.64, 95% CI 0.42–0.96).
In contrast, smokers with cardiovascular disease at S2 (OR
1.54, 95% CI 1.05–2.28) or having become owners of a
dog between S1 and S2 (OR 1.78, 95% CI 1.12–2.83) were
significantly more likely to quit smoking. A history of can-
cer was also a positive albeit not significant predictor of
quitting by S3 (OR 1.54, 95% CI 0.79–2.99). Associations
of smoking cessation between S2 and S3 with the variables
re-assessed at S2 showed similar odds ratios with and with-
out adjustment for the variables newly assessed in S2, and
patterns of statistical significance were identical (supple-
mentary table S2 in appendix 2).
A further analysis studying the relationship between smok-
ing cessation and the Tiffeneau ratio FEV1/FVC was per-
formed (fig. 1). The probability of quitting showed a U-
shaped dependency on the FEV1/FVC ratio with highest
probabilities of quitting at the two ends of the spectrum.
However, the most important finding was that the probabil-
Table 3: Estimated independent associations of smoking cessation
between SAPALDIA2 (2002) and SAPALDIA3 (2010/11) with different
personal characteristics newly introduced in SAPALDIA21.
Odds ratio (95% CI)
Alcohol consumption
Less than once a week 1
Less than once a day 0.94 (0.66–1.34)
1 or 2 times a day 0.64* (0.42–0.96)
≥3 times a day 2.18 (0.88–5.43)
Physical Activity
Insufficiently active 1
Sufficiently active2 0.98 (0.73–1.32)
New dog ownership3 1.78* (1.12–2.83)
Diabetes4 0.99 (0.42–2.31)
Cancer4 1.54 (0.79–2.99)
Depression4 0.53* (0.30–0.93)
Cardiovascular disease5 1.54* (1.05–2.28)
1 Results from multivariable logistic regression model (among persons
who were smokers at SAPALDIA2) with outcome = “having quit smok-
ing by SAPALDIA3” and covariates defined at SAPALDIA2. The model
included all variables listed in the table along with sex, age, study area,
education level, civil status, nationality, overweight, mean daily dura-
tion of environmental tobacco smoke exposure, daily number of ciga-
rettes smoked, presence of chronic cough, presence of chronic phlegm,
doctor’s diagnosed asthma and Tiffeneau ratio (FEV1/FVC). 2 At least
150min/week of moderate or vigorous physical activity 3 Reported own-
ership of a dog in SAPALDIA2 but not yet in SAPALDIA1. 4 Diagnosed
by a doctor 5 Hypertension, stroke and/or intake of heart medication * p
<0.05
Table 1: Characteristics of the cohort at the three surveys of SAPALDIA in 1991, 2002 and 2010/11 by smoking status.
SAPALDIA 1 (1991) SAPALDIA 2 (2002) SAPALDIA 3 (2010/11)
Nonsmokers Smokers Nonsmokers Smokers Nonsmokers Smokers
Characteristic n % n % n % n % n % n %
Total 6410 66 3232 34 5906 74 2116 26 4896 81 1113 19
Age (years)
<30 1275 64 719 36 43 75 14 25 0 0 0 0
30–40 1461 62 888 38 975 69 438 31 194 82 42 18
40–50 1837 66 945 34 1296 68 623 32 886 76 277 24
>50 1837 73 680 27 3592 78 1041 22 3816 83 794 17
Sex
Male 2918 62 1822 38 2717 71 1137 30 2285 80 581 20
Female 3492 71 1410 29 3189 77 979 23 2611 83 532 17
Educational Level
≤9 years of school 1028 63 595 37 509 73 189 27 320 80 78 20
12 years of school 4276 67 2117 33 3799 73 1442 28 3171 81 759 19
College or university 1092 68 514 32 1593 77 484 23 1403 84 276 17
Nationality
Swiss 5318 67 2572 33 5071 74 1765 26 4314 82 943 18
Italian, Spanish, Portuguese 684 60 448 40 514 71 213 29 332 77 100 23
W & N European 245 65 132 35 207 71 86 29 167 76 53 24
Eastern European 69 64 38 36 43 65 23 35 28 78 8 22
Others 86 69 39 31 65 75 22 25 48 89 6 11
Civil status
Married 4238 69 1898 31 3554 77 1050 23 2893 85 524 15
Divorced 340 54 288 46 394 66 207 34 458 74 159 26
Widowed 124 72 49 28 239 80 59 20 298 87 43 13
Single 1703 63 996 37 736 69 324 31 518 77 149 22
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ity of quitting increased with increasing degree of obstruc-
tion among COPD patients.
The last model of smoking cessation between S2 and S3
included the eight scores derived from the SF-36 question-
naire by which participants assessed their health-related
quality of life (table S3, appendix 2). The introduction of
these scores had no sizable influence on the associations
of quitting with the disease variables or other predictors
of smoking cessation considered. Only two out of eight
scores of the SF-36 survey showed a significant associa-
tion with quitting. These associations are shown in a forest
plot (fig. 2).
Smokers with a low energy and vitality index were sig-
nificantly more likely to quit smoking (OR 2.03, 95% CI
1.12–3.68, ref. high energy and vitality index). In contrast,
persons with a lower social functioning score were less
likely to quit (OR 0.63, 95% CI 0.39–1.03, ref. high social
functioning).
Results obtained upon inverse probability weighting were
very similar to the original ones (tables S4 and S5, appen-
dix 2).
Discussion
The findings of our study are consistent with results from
the Swiss Health Survey, which documented a decrease in
smoking prevalence from the early nineties to about 2010
in Switzerland [6, 13]. However, in our study the decrease
was faster, which is partly explained by the stronger loss to
follow-up among smokers in our cohort, but possibly also
by the fact that our cohort aged by 20 years and therefore
no longer includes the youngest age groups. The percent-
age of smokers was 19% in our cohort in 2010/11, whereas
the corresponding figure was 28% in the National Health
Survey in 2012. However, there is strong evidence that
smoking has not decreased among young Swiss adults in
the last decade [13]. If the percentage of smokers is com-
puted for adults aged 35 years or more (i.e., roughly corre-
sponding to the age range of our cohort in the third survey)
using data of the Swiss National Health Survey, the esti-
mated percentage of smokers in 2012 reduces to 25%.
Across the three surveys of SAPALDIA in 1991, 2002 and
2010/11, both genders showed an increasing proportion
Table 2: Estimated independent associations of smoking cessation between surveys with different personal characteristics1.
1991–2002 2002–2010/11 1991–2010/11
Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI)
Sex (at 50 years)
Men 1 1 1
Women 0.64* (0.49–0.85) 0.88 (0.65–1.17) 0.74* (0.61–0.91)
Age (years)
In men 1.02* (1.01–1.04) 1.02* (1.00–1.04) 1.02* (1.01–1.03)
In women 1.00 (0.98–1.01) 1.01 (0.99–1.03) 1.00 (0.99–1.01)
Civil status
Married 1.00 1.00 1.00
Divorced 1.42* (1.01–2.01) 1.26 (0.83–1.90) 1.35* (1.04–1.76)
Widowed 2.21* (1.08–4.54) 2.20 (0.99–4.87) 2.21* (1.29–3.76)
Single 1.17 (0.91–1.49) 1.31 (0.90–1.89) 1.21 (0.98–1.48)
Education level2
Low 1.00 1.00 1.00
Medium 1.04 (0.78–1.37) 2.75* (1.30–5.82) 1.17 (0.90–1.52)
High 1.31 (0.92–1.86) 2.94* (1.33–6.49) 1.49* (1.08–2.06)
Nationality
Swiss 1.00 1.00 1.00
Italian, Spanish, Portuguese 1.00 (0.72–1.39) 0.85 (0.50–1.44) 0.96 (0.72–1.26)
W & N European 0.80 (0.49–1.31) 0.86 (0.43–1.71) 0.82 (0.55–1.22)
Eastern European 0.73 (0.20–2.67) 1.62 (0.46–5.75) 1.10 (0.45–2.72)
Other 1.82 (0.69–4.76) 0.60 (0.11–3.32) 1.39 (0.60–3.22)
Overweight3 1.38* (1.11–1.71) 1.38* (1.03–1.84) 1.38 (1.16–1.64)
No. cigarettes / day 0.97* (0.97–0.98) 0.95* (0.94–0.97) 0.97* (0.96, 0.98)
Daily ETS exposure4
None 1.00 1.00 1.00
<3 hrs 1.07 (0.84–1.36) 1.01 (0.73–1.39) 1.05 (0.86–1.27)
≥3 hrs 0.86 (0.69–1.07) 1.05 (0.72–1.55) 0.90 (0.74–1.10)
Chronic cough5 0.96 (0.66–1.39) 0.88 (0.51–1.52) 0.94 (0.69–1.27)
Chronic phlegm5 0.89 (0.53–1.48) 0.59 (0.30–1.18) 0.77 (0.51–1.16)
Asthma6 0.94 (0.62–1.43) 0.49* (0.26–0.91) 0.77 (0.54–1.08)
FEV1/FVC ratio7
≥0.7 1.00 1.00 1.00
0.5–0.7 1.10 (0.82–1.47) 0.99 (0.70–1.39) 1.05 (0.84–1.31)
<0.5 3.86 (0.93–16.0) 8.87* (2.57–30.6) 6.19* (2.44–15.7)
1 Results for the periods 1991 (SAPALDIA1) – 2002 (SAPALDIA2) and 2002 – 2010 / 11 (SAPALDIA3) are from multivariable logistic regression models (among persons who
were smokers at the start of the period) with outcome = “having quit smoking by the end of the period” and covariates including study area and all variables listed in the table (as
assessed at the beginning of the period). Results for the entire period 1991 – 2010/11 were obtained as meta-analytic summary estimates of the period-specific results. 2 Low =
≤9 years of school; medium = 12 years of school; high = college or university 3 Body mass index >25 kg/m2 4 Mean duration of daily exposure to environmental tobacco smoke 5
Regular occurrence of respective symptom for ≥3 months per year and since at least 2 years 6 Confirmed by a doctor 7 FVC = forced vital lung capacity, FEV1 = forced expiratory
volume in one second * p <0.05
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of former smokers and a decreasing prevalence of current
smoking. This trend was previously reported in another
Swiss study [6], as well as in other countries such as Spain
[14], the UK and Australia [15]. Overall, men had a high-
er proportion of current smokers over time than women,
but the sex difference decreased over time. Our findings
of a decreasing smoking trend in both men and women
with a slower decrease rate among women are in agree-
ment with other studies in high-income countries [14–17],
where this is described as a consequence of the later adop-
tion of smoking as a widespread habit by women. Reasons
for this time lag include multiple sociocultural factors such
as social disapproval of female smoking in the early twen-
Figure 1: Estimated probability of quitting smoking between 1991
and 2002 as a function of FEV1/FVC in 1991, with 95% confidence
limits*.1 Defined according to the GOLD report definition*derived
from a logistic regression model of smoking cessation between
1991 and 2002 containing a natural cubic spline function of base-
line FEV1/FVC and adjusting for age, sex, study area, civil status,
educational level, nationality, BMI, parental smoking, exposure to
environmental tobacco smoke, number of cigarettes smoked per
day and presence of respiratory conditions (chronic cough, chronic
phlegm and asthma) at baseline
Figure 2: Smoking cessation between 2002 and 2010/11 and
quality of life in 2002.SF36 index categories: low <25, medium
≥25/<75, high ≥75.Odds ratios of smoking cessation between
SAPALDIA2 (2002) and SAPALDIA3 (2010/11) associated with
SF36-scores of “social functioning” and “energy and vitality” are
adjusted for age, sex, study area, civil status, educational level,
nationality, BMI, exposure to environmental tobacco smoke, num-
ber of cigarettes smoked per day, alcohol consumption, physical
activity, new dog ownership, presence of chronic cough, chronic
phlegm and asthma, depression, diabetes, cardiovascular disease,
cancer and pulmonary function. There was no evidence of any as-
sociation between smoking cessation and the other SF36-scores.
tieth century, gender role norms, less employment among
females and a higher religious commitment in women [18].
Possible causes of this closing gap between females and
males, recently described in the WHO bulletin [19], in-
clude increasing societal tolerance toward smoking women
[15], growing economic resources among women and the
tobacco industry’s targeting of women by featuring smok-
ing as a symbol of independence and social desirability
[20, 21].
Sociodemographic and lifestyle predictors of quitting
Our findings indicate that higher educational level, being
divorced or widowed and age in men are significant pre-
dictors of smoking cessation. These results are consistent
with those of previous research in Switzerland [6, 22] Eu-
rope [8, 23, 24], and the USA [25], where higher odds of
quitting were linked to male gender, aging, higher educa-
tion, marital status and higher socioeconomic status.
That overweight smokers were more likely to quit was un-
expected. A similar finding was made in two European co-
hort studies, of which the first was conducted in Germany,
where the cessation rate increased significantly with in-
creasing BMI [26], and the second in Ireland where having
a BMI ≥25 kg/m2 was positively associated with quitting
[27]. In contrast, a study conducted in the USA [28] report-
ed a lower cessation rate among overweight persons and
explained this by concerns about gaining weight expressed
by overweight smokers, particularly women.
New dog ownership as a positive predictor of quitting was
another unanticipated finding. Although there is some ev-
idence that having a pet can motivate healthy behaviour
changes [29, 30], this finding would need to be confirmed
by other studies.
In contrast, the likelihood of quitting was lower in women
and decreased with increasing number of cigarettes
smoked per day, an indicator of dependency. Multiple stud-
ies have found that heavier smokers are more likely to con-
tinue smoking in the long term [8, 11, 24, 31]. This neg-
ative relation between nicotine dependence and smoking
cessation may be used as a basis for a personalised ap-
proach to nicotine replacement therapy (NRT). For exam-
ple, a previous study in twins showed that 40 to 60% of the
individual differences in the ability to quit smoking and, to
some extent also the propensity for nicotine dependence,
are genetically determined [32]. As a consequence, the ef-
fectiveness of NRT could be improved by differentiating
the dose of nicotine replacement according to the level of
dependency and the genotype of the smoker [33].
We additionally performed an analysis looking at the prob-
ability of quitting before S1. Interestingly, patients with
asthma and women were more likely to quit before
SAPALDIA 1, suggesting that persons from these two
groups who were still smoking at the baseline survey had
increased nicotine dependency. This might provide another
explanation for the negative association of these two char-
acteristics with quitting.
Health-related predictors of smoking cessation
Among the health-related variables included in our study,
cardiovascular disease and severe airway obstruction
showed a positive association with quitting, whereas per-
sons with asthma, chronic phlegm or depression were less
likely to quit. A negative association between smoking
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cessation and chronic sputum production was also found
in a recent smoking cessation intervention study conducted
among 887 smoking employees in the city of Basel [34].
The coexistence of smoking and depression has been ex-
tensively investigated, mainly because depression is the
psychiatric disorder most associated with tobacco use [35].
Similar to our results, the aforementioned intervention
study in Basel showed that smokers with a history of de-
pression or current use of antidepressants were less likely
to quit [34]. This may be related to common genetic mech-
anisms behind smoking initiation, nicotine dependence and
depressive disorders [36, 37].
According to the European Respiratory Society-Task force
guidelines, respiratory patients who smoke are a difficult
target group for smoking cessation, as they tend to min-
imise their own perceived risk of disease. Even in ad-
vanced stages of COPD, when quality of life is low, a
smoking patient could consider cigarettes as an important
factor for his/her quality of life [38]. Therefore, these pa-
tients need strong encouragement and continued coun-
selling support for overcoming their addiction [39].
Our data on the health-related quality of life assessed with
the SF-36 questionnaire showed that current smokers with
a lower vitality score had a higher probability of quitting,
whereas those with a lower social functioning score were
less likely to quit. This is consistent with the results of
previous studies, where persons who continued smoking
had lower social functioning scores than those who quitted
smoking [40, 41]. Moreover, a higher number of cigarettes
smoked per day has been significantly associated with a
lower vitality score [40, 42], possibly reflecting impaired
physical health. However, in our study the association was
observed after adjusting for chronic diseases and even in
a sensitivity analysis where we excluded the participants
with chronic diseases (data not shown).
Swiss smoking bans and smoking cessation
The decrease in smoking prevalence between SAPALDIA
2 and SAPALDIA 3 could also be related to the introduc-
tion of smoking bans at the cantonal level. However, we
could not assess the impact of these smoke-free laws be-
cause of the shortness of the follow-up time after the im-
plementation of the bans and the imprecise information on
the quitting age of many study subjects.
Strengths and limitations
Our study is based on a large multi-regional population
sample, which was followed up over 20 years, and from
which an extensive database on sociodemographic, envi-
ronmental, lifestyle and health characteristics of the study
participants could be established. The large number of dif-
ferent predictor variables considered is both a strength and
a limitation of the study. It reduces the risk of confound-
ing, but increases alpha error inflation. Loss to follow-up,
which is common in long-term cohort studies, is a limita-
tion. To address this concern, we performed inverse proba-
bility weighting involving predictor variables of follow-up
participation. This led to only minor changes in the ob-
served associations. Although this does not rule out the
presence of some remaining bias, it makes major attrition
bias less likely. Although the SAPALDIA study includes
local populations from urban and rural communities and
from the three major language regions of Switzerland, the
present results may not be fully generalisable to the adult
population of Switzerland, as study areas were not selected
randomly. Moreover, as the cohort aged during follow-up,
our results cannot be generalised to younger adults. An-
other limitation is the self-report of smoking status. But
self-reported smoking status was shown to have good va-
lidity in several population based studies [43, 44] and we
had found end-expiratory carbon monoxide measurements
in SAPALDIA2 to discriminate well between quitters and
non-quitters in the first follow-up period, with an area un-
der the receiver-operating-characteristic curve of 0.91.
Conclusion
Our data confirm the decrease in smoking prevalence in
Switzerland over the period 1991 to 2011. Our findings
regarding individual characteristics associated with smok-
ing cessation are relevant tools for personalised approaches
in tobacco control at the policy and at the personal level,
as they point to subgroups in need for additional support
such as pharmacological treatment of nicotine addiction.
Prospective public health policies against tobacco use in
Switzerland should be particularly focused to women,
younger persons and persons of lower education. Persons
with respiratory problems, depression or signs of high
nicotine dependence need personalised support.
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Appendix 1
SAPALDIA Team
Study directorate: NM Probst-Hensch (PI; e/g); T Rochat
(p), N Künzli (e/exp), C Schindler (s), JM Gaspoz (c).
Scientific team: JC Barthélémy (c), W Berger (g), R
Bettschart (p), A Bircher (a), O Brändli (p), C Brombach
(n), L Burdet (p), M Frey (p), U Frey (pd), MW Gerbase
(p), D Gold (e), E de Groot (c), W Karrer (p), M Kohler
(p), B Martin (pa), D Miedinger (o), L Nicod (p), M Pons
(p), F Roche (c), T Rothe (p), P Schmid-Grendelmeyer (a),
A Schmidt-Trucksäss (pa), A Turk (p), J Schwartz (e), D.
Stolz (p), P Straehl (exp), JM Tschopp (p), A von Eckard-
stein (cc), E Zemp Stutz (e).
Scientific team at coordinating centers: M Adam (e/g),
I Aguilera (e), C Autenrieth (pa), PO Bridevaux (p), D
Carballo (c), I Curjuric (e), J Dratva (e), R Ducret (s), E
Dupuis Lozeron (s), M Eeftens (exp), I Eze (e), E Fischer
(g), M Germond (s), L Grize (s), S Hansen (e), A Hensel
(s), M Imboden (g), A Ineichen (exp), D Keidel (s), A
Kumar (g), N Maire (s), A Mehta (e), R Meier (exp), E
Schaffner (s), T Schikowski (e), GA Thun (g), M Tarantino
(s), M Tsai (e)
(a) allergology, (c) cardiology, (cc) clinical chemistry, (e)
epidemiology, (exp) exposure, (g) genetic and molecular
biology, (m) meteorology, (n) nutrition, (o) occupational
health, (p) pneumology, (pa) physical activity, (pd) pedi-
atrics, (s) statistics
Local fieldworkers: Aarau: S Brun, G Giger, M Sperisen,
M Stahel, Basel: C Bürli, C Dahler, N Oertli, I Harreh,
F Karrer, G Novicic, N Wyttenbacher, Davos: A Saner, P
Senn, R Winzeler, Geneva: F Bonfils, B Blicharz, C Lan-
dolt, J Rochat, Lugano: S Boccia, E Gehrig, MT Man-
dia, G Solari, B Viscardi, Montana: AP Bieri, C Darioly,
M Maire, Payerne: F Ding, P Danieli A Vonnez, Wald:
D Bodmer, E Hochstrasser, R Kunz, C Meier, J Rakic, U
Schafroth, A Walder.
Administrative staff: C Gabriel, R Gutknecht.
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Table S1: Description of the samples included in the analyses of smoking cessation.
Sample 11
(n = 2245)
Sample 21
(n = 1075)
Count % Count %
Age
<30 yrs 512 22.8 7 0.7
30–40 yrs 634 28.2 226 21
40–50 yrs 656 29.2 353 32.8
>50 yrs 443 19.7 489 45.5
Sex
Male 1175 52.3 560 52.1
Female 1070 47.7 515 47.9
Civil status
Married 1334 59.4 693 64.5
Divorced 182 8.1 143 13.3
Widowed 35 1.6 32 3
Single 694 30.9 207 19.3
Educational Level2
Low 364 16.2 54 5
Medium 1536 68.4 735 68.4
High 345 15.4 286 26.6
Nationality
Swiss 1883 83.9 923 85.9
Italian, Spanish, Portuguese 238 10.6 89 8.3
Western & northern European 91 4 45 4.2
Eastern European 15 0.7 11 1
Other 18 0.8 7 0.7
Overweight3 690 30.7 494 46
No. cigarettes per day, median (IQR) 15 (8, 20) 12 (5, 20)
Daily ETS exposure4
None 922 41.1 552 51.4
<3 hrs 518 23.1 323 30
≥3 hrs 805 35.9 200 18.6
Chronic cough5 187 8.3 102 9.5
Chronic phlegm5 92 4.1 69 6.4
Asthma6 121 5.4 73 6.8
FEV1/FVC ratio 7
≥0.7 1945 86.6 807 75.1
0.5–0.7 291 13 254 23.6
<0.5 9 0.4 14 1.3
Cardiovascular disease8 176 16.4
Diabetes6 17 1.6
Cancer6 (n = 1074) 47 4.4
Depression6 88 8.2
New dog ownership9 107 10
Suffcient physical activity (n = 1072) 10 694 64.7
Alcohol consumption (n = 1073)
Less than once a week 256 23.9
Less than once a day 502 46.8
1–2 times per day 282 26.3
≥3 times per day 33 3.1
1 Sample 1 = smokers at SAPALDIA1 (1991) with known smoking status at SAPALDIA2 (2002) and complete information on age to Tiffeneau ratio at SAPALDIA1; Sample 2 =
smokers at SAPALDIA2 (2002) with known smoking status at SAPALDIA3 (2010/11) and complete information on variables Age to Tiffeneau ratio in SAPALDIA2. 2 Low = ≤ 9
years of school; medium = 12 years of school; high = college or university 3 Body mass index >25 kg/m2 4 Mean duration of daily exposure to environmental tobacco smoke 5
regular occurrence of respective symptom for ≥3 months per year and since at least 2 years 6 Confirmed by a doctor 7 FVC = forced vital lung capacity, FEV1 = forced expiratory
volume in one second 8 Hypertension, stroke and/or intake of heart medication 9 Reported ownership of a dog in SAPALDIA2 but not yet in SAPALDIA1 10 At least 150 min/week
of moderate or vigorous physical activity
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Table S2: Estimated independent associations of smoking cessation between SAPALDIA2 (2002) and SAPALDIA3 (2010/11) with different personal characteristics assessed at
SAPALDIA21, comparison of basic and extended model.
Extended model2 Basic model2
Characteristic Odds ratio (95% CI) Odds Ratio (95% CI)
Sex (at 50 years)
Male 1 1
Female 0.86 (0.63–1.18) 0.88 (0.65–1.17)
Age (years)
In men 1.02 (1.00–1.04) 1.02* (1.00–1.04)
In women 1.01 (0.99–1.03) 1.01 (0.99–1.03)
Civil status
Married 1 1.00
Divorced 1.36 (0.89–2.08) 1.26 (0.83–1.90)
Widowed 2.68* (1.19–6.06) 2.20 (0.99–4.87)
Single 1.42 (0.97–2.07) 1.31 (0.90–1.89)
Educational level3
Low 1 1.00
Medium 2.63* (1.22–5.66) 2.75* (1.30–5.82)
High 2.91* (1.29–6.58) 2.94* (1.33–6.49)
Nationality
Swiss 1 1.00
Italian, Spanish, Portuguese 0.74 (0.43–1.29) 0.85 (0.50–1.44)
W & N European 0.92 (0.46–1.84) 0.86 (0.43–1.71)
Eastern European 1.62 (0.44–5.94) 1.62 (0.46–5.75)
Other 0.44 (0.08–2.52) 0.60 (0.11–3.32)
Overweight4 1.36* (1.01–1.84) 1.38* (1.03–1.84)
No. of cigarettes/day 0.95* (0.94–0.96) 0.95* (0.94–0.97)
Daily ETS exposure5
None 1 1.00
<3 hours 1.00 (0.72–1.39) 1.01 (0.73–1.39)
≥3 hours 0.98 (0.66–1.46) 1.05 (0.72–1.55)
Chronic cough6 0.92 (0.53–1.60) 0.88 (0.51–1.52)
Chronic phlegm6 0.54 (0.26–1.10) 0.59 (0.30–1.18)
Asthma7 0.52* (0.28–0.96) 0.49* (0.26–0.91)
FEV1/FVC ratio 8
≥0.7 1 1.00
0.5–0.7 0.94 (0.66–1.33) 0.99 (0.70–1.39)
<0.5 10.75*** (3.05–37.9) 8.87* (2.57–30.6)
Alcohol consumption
Less than once a week 1
Less than once a day 0.94 (0.66–1.34)
1 or 2 times a day 0.64* (0.42–0.96)
≥3 times a day 2.18 (0.88–5.43)
Physical Activity9
Insufficiently active 1
Sufficiently active 0.98 (0.73–1.32)
New dog ownership10 1.78* (1.12–2.83)
Diabetes11 0.99 (0.42–2.31)
Cancer11 1.54 (0.79–2.99)
Depression11 0.53* (0.30–0.93)
Cardiovascular disease12 1.54* (1.05–2.28)
1 Results from multivariable logistic regression model (among persons who were smokers at SAPALDIA2) with outcome = “having quit smoking by SAPALDIA3” and covariates
defined at SAPALDIA2. 2 Basic model includes covariates which were already assessed in SAPALDIA1: sex, age, study area. education level, civil status, nationality, overweight,
mean daily duration of ETS-exposure, daily number of cigarettes smoked, presence of chronic cough, presence of chronic phlegm, doctor’s diagnosed asthma and Tiffeneau ratio
(FEV1/FVC). Extended model additionally includes variables introduced in SAPALDIA2. 3 Low = ≤9 years of school; medium = 12 years of school; high = college or university 4
Body mass index >25 kg/m2 5 Mean duration of daily exposure to environmental tobacco smoke 6 Regular occurrence of respective symptom for ≥3 months per year and for at
least 2 years 7 confirmed by a doctor 8 FVC = forced vital lung capacity, FEV1 = forced expiratory volume in one second 9 At least 150 min/week of moderate or vigorous physical
activity 10 Reported ownership of a dog in SAPALDIA2 but not in SAPALDIA1. 11 diagnosed by a doctor 12 Hypertension, stroke and/or intake of heart medication * p <0.05
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Table S3: Estimated independent associations of smoking cessation between SAPALDIA2 (2002) and SAPALDIA3 (2010/11) with indicators of health related quality of life
(SF36) assessed at SAPALDIA2 (n = 880)1.
Odds ratio (95% CI)
Health Status (SF-36 questionnaire)
SF36 Pain 1.00 (0.99–1.01)
SF36 general health perceptions 1.00 (0.99–1.02)
SF36 mental health 0.99 (0.98–1.01)
SF36 physical functioning 1.00 (0.99–1.01)
SF36 role-emotional 1.01 (1.00–1.01)
SF36 role-physical 1.00 (0.99–1.00)
SF36 Social Functioning2
Low 0.63 (0.39–1.03)
Medium 0.78 (0.50–1.24)
High 1 Ref.
SF36 Energy and Vitality2
Low 2.03* (1.12–3.68)
Medium 1.41 (0.89–2.22)
High 1
Adjustment variables
Sex (at 50 years)
Male 1
Female 0.78 (0.54–1.12)
Age (years)
In men 1.02 (1.00–1.04)
In women 1.01 (0.98–1.03)
Civil status
Married 1
Divorced 1.54 (0.96–2.47)
Widowed 2.65* (1.04–6.78)
Single 1.57* (1.02–2.40)
Educational level
Low 1
Medium 2.3 (0.96–5.52)
High 2.81* (1.12–7.07)
Nationality
Swiss 1
Italian, Spanish, Portuguese 0.55 (0.29–1.06)
W & N European 0.78 (0.34–1.79)
Eastern European 2.16 (0.37–12.58)
Other 0.35 (0.06–2.05)
Overweight 1.37 (0.97–1.93)
No. of cigarettes per day 0.95* (0.94–0.97)
Alcohol consumption
Less than once a week 1
Less than once a day 0.94 (0.62–1.41)
1 or 2 times a day 0.60* (0.37–0.96)
≥3 times a day 1.50 (0.54–4.18)
Physical Activity
Insufficiently active 1
Sufficiently active 0.84 (0.60–1.17)
New dog ownership 1.76* (1.06–2.92)
Daily ETS exposure
None 1
<3 hours 1.10 (0.76–1.60)
≥3 hours or more 1.08 (0.69–1.69)
Chronic cough 1.00 (0.55–1.81)
Chronic phlegm 0.69 (0.32–1.51)
Asthma 0.51 (0.24–1.07)
FEV1/FVC ratio
≥0.7 1
0.5–0.7 0.92 (0.62–1.36)
<0.5 11.0* (2.26–52.9)
Diabetes 0.87 (0.33–2.25)
Cancer 1.87 (0.82–4.29)
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Odds ratio (95% CI)
Depression 0.58 (0.29–1.17)
Cardiovascular disease 1.83* (1.17–2.86)
1 Results from multivariable logistic regression model (among persons who were smokers at SAPALDIA2) with outcome = “having quit smoking by SAPALDIA3” and covariate
part consisting of study area and all variables listed in the table. 2 low = score <25; medium = 25 ≤score <75; high = score ≥75
Table S4: Estimated independent associations of smoking cessation between SAPALDIA1 (1991) and SAPALDIA2 (2002) with different personal characteristics assessed at
SAPALDIA1, without and with inverse probability weighting (IPW).
Without IPW With IPW
Characteristic Odds ratio (95% CI) Odds ratio (95% CI)
Sex (at 50 years)
Male 1 1
Female 0.64* (0.49–0.85) 0.63* (0.48–0.84)
Age (years)
In men 1.02* (1.01–1.04) 1.02* (1.01–1.04)
In women 0.99 (0.98–1.01) 0.99 (0.98–1.01)
Civil status
Married 1 1
Divorced 1.43* (1.01–2.01) 1.45* (1.03–2.06)
Widowed 2.21* (1.08–4.54) 2.16* (1.09–4.26)
Single 1.16 (0.91–1.49) 1.19 (0.93–1.51)
Educational level2
Low 1 1
Medium 1.04 (0.78–1.37) 1.06 (0.80–1.40)
High 1.31 (0.92–1.86) 1.33 (0.93–1.90)
Nationality
Swiss 1 1
Italian, Spanish, Portuguese 1.00 (0.72–1.39) 0.98 (0.70–1.38)
W & N European 0.80 (0.49–1.31) 0.81 (0.50–1.32)
Eastern European 0.73 (0.20–2.67) 0.64 (0.13–3.12)
Other 1.82 (0.69–4.76) 1.84 (0.65–5.26)
Overweight3 1.38* (1.11–1.71) 1.36* (1.09–1.70)
No. of cigarettes/day 0.97* (0.97–0.98) 0.98* (0.97–0.99)
Daily ETS exposure4
None 1 1
<3 hours 1.07 (0.84–1.36) 1.07 (0.84–1.37)
≥3 hours 0.86 (0.69–1.07) 0.88 (0.70–1.11)
Chronic cough5 0.96 (0.66–1.39) 0.95 (0.65–1.37)
Chronic phlegm5 0.89 (0.53–1.48) 0.91 (0.54–1.55)
Asthma6 0.94 (0.62–1.43) 0.90 (0.58–1.40)
FEV1/FVC ratio7
≥0.7 1 1
0.5–0.7 1.10 (0.82–1.47) 1.15 (0.85–1.55)
<0.5 3.86 (0.93–15.95) 4.41* (1.03–18.9)
1 Results from multivariable logistic regression models (among persons who were smokers at SAPALDIA1) with outcome = “having quit smoking by SAPALDIA2” and covariate
part consisting of study area and all variables listed in the table. Probability weights were derived from a logistic regression model for the outcome “participation in SAPALDIA2”
involving variables from SAPALDIA1 associated with participation in SAPALDIA2. 2 Low = ≤9 years of school; medium = 12 years of school; high = college or university 3 Body
mass index >25 kg/m2 4 Mean duration of daily exposure to environmental tobacco smoke 5 Regular occurrence of respective symptom for ≥3 months per year and for at least 2
years 6 Confirmed by a doctor 7 FVC = forced vital lung capacity, FEV1 = forced expiratory volume in one second
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Table S5: Estimated independent associations of smoking cessation between SAPALDIA2 (2002) and SAPALDIA3 (2010/11) with different personal characteristics assessed at
SAPALDIA2, without and with inverse probability weighting (IPW).
Without IPW With IPW
Characteristic Odds ratio (95% CI) Odds ratio (95% CI)
Sex (at 50 years)
Male 1 1
Female 0.78 (0.54-1.12) 0.78 (0.55-1.12)
Age (years)
In men 1.02 (1.00-1.04) 1.02 (1.00-1.04)
In women 1.01 (0.98-1.03) 1.00 (0.98-1.03)
Civil status
Married 1 1
Divorced 1.54 (0.96-2.47) 1.48 (0.92-2.38)
Widowed 2.65* (1.04-6.78) 2.90* (1.17-7.17)
Single 1.57* (1.02-2.40) 1.62* (1.06-2.47)
Educational level2
Low 1 1
Medium 2.3 (0.96-5.52) 2.09 (0.90-4.86)
High 2.81* (1.12-7.07) 2.57* (1.04-6.36)
Nationality
Swiss 1 1
Italian, Spanish, Portuguese 0.55 (0.29-1.06) 0.56 (0.29-1.07)
W & N European 0.78 (0.34-1.79) 0.74 (0.32-1.72)
Eastern European 2.16 (0.37-12.58) 2.65 (0.41-16.96)
Other 0.35 (0.06-2.05) 0.34 (0.06-2.07)
Overweight3 1.37 (0.97-1.93) 1.36 (0.96-1.91)
No. of cigarettes/day 0.95* (0.94-0.97) 0.96* (0.94-0.97)
Daily ETS exposure4
None 1 1
<3 hours 1.10 (0.76-1.60) 1.13 (0.77-1.66)
≥3 hours 1.08 (0.69-1.69) 1.08 (0.69-1.70)
Chronic cough5 1.00 (0.55-1.81) 1.00 (0.53-1.89)
Chronic phlegm5 0.69 (0.32-1.51) 0.70 (0.33-1.49)
Asthma6 0.51 (0.24-1.07) 0.50 (0.25-1.01)
FEV1/FVC ratio7
≥0.7 1 1
0.5–0.7 0.92 (0.62-1.36) 0.94 (0.63-1.41)
<0.5 10.95* (2.26-52.9) 8.06* (1.14-56.9)
Alcohol consumption
Less than once a week 1 1
Less than once a day 0.94 (0.62-1.41) 0.92 (0.61-1.41)
1 or 2 times a day 0.60* (0.37-0.96) 0.58* (0.36-0.94)
≥ 3 times a day 1.50 (0.54-4.18) 1.35 (0.53-3.48)
Physical Activity
Insufficiently active 1 1
Sufficiently active8 0.84 (0.60-1.17) 0.86 (0.61-1.19)
New dog ownership9 1.76* (1.06-2.92) 1.69* (1.01-2.82)
Diabetes10 0.87 (0.33-2.25) 1.01 (0.36-2.83)
Cancer10 1.87 (0.82-4.29) 1.95 (0.85-4.49)
Depression10 0.58 (0.29-1.17) 0.58 (0.30-1.14)
Cardiovascular disease11 1.83* (1.17-2.86) 1.95* (1.23-3.09)
Health Status (SF-36 survey)
SF36 Pain 1.00 (0.99-1.01) 1.00 (0.99-1.01)
SF36 general health perceptions 1.00 (0.99-1.02) 1.00 (0.99-1.02)
SF36 mental health 0.99 (0.98-1.01) 0.99 (0.98-1.01)
SF36 physical functioning 1.00 (0.99-1.01) 1.00 (0.99-1.01)
SF36 role-emotional 1.01 (1.00-1.01) 1.00 (1.00-1.01)
SF36 role-physical 1.00 (0.99-1.00) 1.00 (0.99-1.00)
SF36 Social Functioning12
Low 0.62 (0.39-1.03) 0.60* (0.37-0.97)
Medium 0.78 (0.50-1.24) 0.74 (0.47-1.17)
High 1 1
SF36 Energy and Vitality12
Low 2.03* (1.12-3.68) 2.02* (1.11-3.68)
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Without IPW With IPW
Characteristic Odds ratio (95% CI) Odds ratio (95% CI)
Medium 1.41 (0.89-2.22) 1.39 (0.88-2.21)
High 1 1
1 Results from multivariable logistic regression models (among persons who were smokers at SAPALDIA2) with outcome = “having quit smoking by SAPALDIA3” and covariate
part consisting of study area and all variables listed in the table. Probability weights were derived from a logistic regression model for the outcome “participation in SAPALDIA3”
involving variables from SAPALDIA2 associated with participation in SAPALDIA3. 2 Low = ≤9 years of school; medium = 12 years of school; high = college or university 3 Body
mass index >25 kg/m2 4 Mean duration of daily exposure to environmental tobacco smoke 5 Regular occurrence of respective symptom for ≥3 months per year and for at least
2 years 6 Confirmed by a doctor 7 FVC = forced vital lung capacity, FEV1 = forced expiratory volume in one second 8 At least 150 min/week of moderate or vigorous physical
activity 9 Reported ownership of a dog in SAPALDIA2 but not in SAPALDIA1. 10 Diagnosed by a doctor 11 Hypertension, stroke and/or intake of heart medication 12 low = score
<25; medium = 25 ≤score <75; high = score ≥75 * p < 0.05
Table S6: Estimated independent associations of smoking cessation between SAPALDIA1 (1991) and SAPALDIA2 (2002) with different personal characteristics assessed at
SAPALDIA1, by gender.
Men Women
Characteristic Odds ratio (95% CI) Odds ratio (95% CI)
Age (years) 1.02* (1.00–1.03) 1.00 (0.98–1.01)
Civil status
Married 1 1
Divorced 2.34* (1.36–4.03) 1.12 (0.70–1.80)
Widowed 2.03 (0.93–4.41)
Single 1.08 (0.75–1.55) 1.24 (0.88–1.76)
Educational level2
Low 1 1
Medium 1.06 (0.71–1.60) 1 (0.67–1.49)
High 1.44 (0.89–2.31) 1.06 (0.60–1.86)
Nationality
Swiss 1 1
Italian, Spanish, Portuguese 1.10 (0.72–1.68) 0.80 (0.47–1.35)
W & N European 0.79 (0.40–1.57) 0.80 (0.39–1.63)
Eastern European 0.91 (0.18–4.70) 0.51 (0.06–4.38)
Other 3.62* (1.08–12.0) 0.39 (0.04–3.50)
Overweight3 1.46* (1.04–2.73) 1.31 (0.91–1.89)
No. of cigarettes/day 0.98* (0.97–0.99) 0.96* (0.94–0.97)
Daily ETS exposure4
None 1 1
<3 hours 1.01 (0.73–1.41) 1.15 (0.81–1.65)
≥3 hours 0.82 (0.60–1.12) 0.90 (0.65–1.25)
Chronic cough5 1.02 (0.64–1.64) 0.81 (0.44–1.49)
Chronic phlegm5 0.80 (0.43–1.48) 1.04 (0.38–2.84)
Asthma6 0.81 (0.45–1.47) 1 (0.54–1.85)
FEV1/FVC ratio7
≥0.7 1 1
0.5–0.7 1.06 (0.73–1.54) 1.13 (0.71–1.82)
<0.5 2.29 (0.72–26.8)
1 Results from multivariable logistic regression models (among persons who were smokers at SAPALDIA1) with outcome = “having quit smoking by SAPALDIA2” and covariate
part consisting of study area and all variables listed in the table. 2 Low = ≤9 years of school; medium = 12 years of school; high = college or university 3 Body mass index >25 kg/
m2 4 Mean duration of daily exposure to environmental tobacco smoke 5 Regular occurrence of respective symptom for ≥3 months per year and for at least 2 years 6 Confirmed
by a doctor 7 FVC = forced vital lung capacity, FEV1 = forced expiratory volume in one second
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Table S7: Estimated independent associations of smoking cessation between SAPALDIA2 (2002) and SAPALDIA3 (2010/11) with different personal characteristics assessed at
SAPALDIA2, by gender.
Men Women
Characteristic Odds ratio (95% CI) Odds ratio (95% CI)
Age (years) 1.02 (0.99–1.05) 1.00 (0.97–1.03)
Civil status
Married 1 1
Divorced 1.21 (0.57–2.55) 1.96 (0.99–3.87)
Widowed 2.2 (0.68–7.12)
Single 1.77 (0.95–3.31) 1.31 (0.68–2.54)
Educational level2
Low 1 1
Medium 1.28 (0.29–5.56) 3.67* (1.04–12.9)
High 1.45 (0.32–6.49) 4.87* (1.23–19.25)
Nationality
Swiss 1 1
Italian, Spanish, Portuguese 0.35* (0.13–0.94) 0.78 (0.28–2.16)
W & N European 0.66 (0.20–2.25) 0.79 (0.22–2.86)
Eastern European 3.69 (0.25–55.0)
Other 0.49 (0.04–6.32) 0.28 (0.02–4.21)
Overweight3 1.68* (1.04–2.73) 1.05 (0.59–1.85)
No. of cigarettes/day 0.97* (0.95–0.99) 0.91* (0.88–0.94)
Daily ETS exposure4
None 1 1
<3 hours 1.32 (0.79–2.22) 0.99 (0.54–1.82)
≥3 hours 1.35 (0.73–2.52) 0.92 (0.54–1.82)
Chronic cough5 1.08 (0.50–2.36) 1.04 (0.36–3.07)
Chronic phlegm5 0.83 (0.41–1.65) 0.27 (0.03–2.40)
Asthma6 0.29* (0.09–0.94) 0.68 (0.23–2.03)
FEV1/FVC ratio7
≥0.7 1 1
0.5–0.7 1.02 (0.60–1.74) 0.83 (0.41–1.65)
<0.5 4.39 (0.72–26.8)
Alcohol consumption
Less than once a week 1 1
Less than once a day 1.40 (0.70–2.79) 0.67 (0.37–1.22)
1 or 2 times a day 0.93 (0.44–1.97) 0.39* (0.18–0.84)
≥ 3 times a day 1.78 (0.54–5.84) 23.40 (0.57–949.9)
Physical Activity
Insufficiently active 1 1
Sufficiently active8 0.79 (0.49–1.28) 1.03 (0.60–1.75)
New dog ownership9 1.87 (0.87–4.01) 2.1 (0.95–4.63)
Diabetes10 0.61 (0.20–1.90) 20 (0.91–439)
Cancer10 2.55 (0.70–9.26) 1.85 (0.56–6.11)
Depression10 0.60 (0.19–1.88) 0.50 (0.18–1.38)
Cardiovascular disease11 1.51 (0.84–2.74) 2.32* (1.02–5.29)
Health Status (SF-36 survey)
SF36 Pain 1.01 (1.00–1.03) 0.99 (0.98–1.01)
SF36 general health perceptions 1.00 (0.99–1.02) 1.01 (0.99–1.03)
SF36 mental health 0.99 (0.97–1.01) 1.00 (0.98–1.03)
SF36 physical functioning 1.00 (0.98–1.02) 0.99 (0.97–1.01)
SF36 role-emotional 1.00 (0.99–1.01) 1.01 (1.00–1.03)
SF36 role-physical 0.99 (0.98–1.01) 1.00 (0.99–1.01)
SF36 Social Functioning12
Low 0.65 (0.32–1.30) 0.50 (0.23–1.09)
Medium 0.64 (0.32–1.28) 0.68 (0.33–1.40)
High 1 1
SF36 Energy and Vitality12
Low 1.91 (0.85–4.33) 2.94* (1.09–7.92)
Medium 1.53 (0.83–2.81) 1.66 (0.75–3.69)
High 1 1
1 Results from multivariable logistic regression models (among persons who were smokers at SAPALDIA2) with outcome = “having quit smoking by SAPALDIA3” and covariate
part consisting of study area and all variables listed in the table. 2 Low = ≤9 years of school; medium = 12 years of school; high = college or university 3 Body mass index >25 kg/
m2 4 Mean duration of daily exposure to environmental tobacco smoke 5 Regular occurrence of respective symptom for ≥3 months per year and for at least 2 years 6 Confirmed by
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a doctor 7 FVC = forced vital lung capacity, FEV1 = forced expiratory volume in one second 8 At least 150 min/week of moderate or vigorous physical activity 9 Reported ownership
of a dog in SAPALDIA2 but not in SAPALDIA1 10 Diagnosed by a doctor 11 Hypertension, stroke and/or intake of heart medication 12 Low = score <25; medium = 25 ≤score <75;
high = score ≥ 5 * p < 0.05
Original article Swiss Med Wkly. 2017;147:w14502
Swiss Medical Weekly · PDF of the online version · www.smw.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 17 of 17
